Abstract
Upadacitinib is a novel selective Janus kinase 1 inhibitor developed for treatment of rheumatoid arthritis and other autoimmune diseases. The objectiv......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
